|
1
|
Global Burden of Disease Cancer
Collaboration, . Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T,
Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, et
al: Global, regional, and national cancer incidence, mortality,
years of life lost, years lived with disability, and
disability-adjusted life-years for 29 cancer groups, 1990 to 2016:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 4:1533–1568. 2018.
|
|
2
|
Waks AG and Winer EP: Breast cancer
treatment. JAMA. 321:3162019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harbeck N, Penault-Llorca F, Cortes J,
Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J and Cardoso F:
Breast cancer. Nat Rev Dis Primers. 5:662019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tao L, Schwab RB, San Miguel Y, Gomez SL,
Canchola AJ, Gago-Dominguez M, Komenaka IK, Murphy JD, Molinolo AA
and Martinez ME: Breast cancer mortality in older and younger
patients in California. Cancer Epidemiol Biomarkers Prev.
28:303–310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saini G, Mittal K, Rida P, Janssen EAM,
Gogineni K and Aneja R: Panoptic view of prognostic models for
personalized breast cancer management. Cancers (Basel).
11:13252019. View Article : Google Scholar
|
|
6
|
Saggar JK, Yu M, Tan Q and Tannock IF: The
tumor microenvironment and strategies to improve drug distribution.
Front Oncol. 3:1542013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chouaib S, Noman MZ, Kosmatopoulos K and
Curran MA: Hypoxic stress: Obstacles and opportunities for
innovative immunotherapy of cancer. Oncogene. 36:439–445. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaupel P, Briest S and Höckel M: Hypoxia
in breast cancer: Pathogenesis, characterization and
biological/therapeutic implications. Wien Med Wochenschr.
152:334–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brooks JM, Menezes AN, Ibrahim M, Archer
L, Lal N, Bagnall CJ, von Zeidler SV, Valentine HR, Spruce RJ,
Batis N, et al: Development and validation of a combined hypoxia
and immune prognostic classifier for head and neck cancer. Clin
Cancer Res. 25:5315–5328. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brueffer C, Vallon-Christersson J, Grabau
D, Ehinger A, Häkkinen J, Hegardt C, Malina J, Chen Y, Bendahl P,
Manjer J, et al: Clinical value of RNA sequencing-based classifiers
for prediction of the five conventional breast cancer biomarkers: A
report from the population-based multicenter sweden cancerome
analysis network. Breast Initiative. 2:1–18. 2018.
|
|
12
|
Kao KJ, Chang KM, Hsu HC and Huang AT:
Correlation of microarray-based breast cancer molecular subtypes
and clinical outcomes: Implications for treatment optimization. BMC
Cancer. 11:1432011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parker JS, Mullins M, Cheang MC, Leung S,
Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al:
Supervised risk predictor of breast cancer based on intrinsic
subtypes. J Clin Oncol. 27:1160–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weigel MT and Dowsett M: Current and
emerging biomarkers in breast cancer: Prognosis and prediction.
Endocr Relat Cancer. 17:R245–R262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Unruh A, Ressel A, Mohamed HG, Johnson RS,
Nadrowitz R, Richter E, Katschinski DM and Wenger RH: The
hypoxia-inducible factor-1 alpha is a negative factor for tumor
therapy. Oncogene. 22:3213–3220. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vaupel P, Kelleher DK and Hckel M:
Oxygenation status of malignant tumors: Pathogenesis of hypoxia and
significance for tumor therapy. Semin Oncol 28 (2 Suppl 8).
S29–S35. 2001.
|
|
19
|
Semenza GL: Angiogenesis in ischemic and
neoplastic disorders. Annu Rev Med. 54:17–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Semenza GL, Roth PH, Fang HM and Wang GL:
Transcriptional regulation of genes encoding glycolytic enzymes by
hypoxia-inducible factor 1. J Biol Chem. 269:23757–23763.
1994.PubMed/NCBI
|
|
21
|
Peng G and Liu Y: Hypoxia-inducible
factors in cancer stem cells and inflammation. Trends Pharmacol
Sci. 36:374–383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ganapathy-Kanniappan S: Molecular
intricacies of aerobic glycolysis in cancer: Current insights into
the classic metabolic phenotype. Crit Rev. Biochem Mol Biol.
53:667–682. 2018.
|
|
23
|
Soysal SD, Tzankov A and Muenst SE: Role
of the tumor microenvironment in breast cancer. Pathobiology.
82:142–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martinez-Outschoorn UE, Trimmer C, Lin Z,
Whitaker Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S,
Martinez-Cantarin MP, Capozza F, et al: Autophagy in cancer
associated fibroblasts promotes tumor cell survival: Role of
hypoxia, HIF1 induction and NFκB activation in the tumor stromal
microenvironment. Cell Cycle. 9:3515–3533. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiong G, Deng L, Zhu J, Rychahou PG and Xu
R: Prolyl-4-hydroxylase α subunit 2 promotes breast cancer
progression and metastasis by regulating collagen deposition. BMC
Cancer. 14:12014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D
and Semenza GL: Hypoxia-inducible factor 1 (HIF-1) promotes
extracellular matrix remodeling under hypoxic conditions by
inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol
Chem. 288:10819–10829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Toss MS, Miligy IM, Gorringe KL, AlKawaz
A, Khout H, Ellis IO, Green AR and Rakha EA: Prolyl-4-hydroxylase A
subunit 2 (P4HA2) expression is a predictor of poor outcome in
breast ductal carcinoma in situ (DCIS). Br J Cancer. 119:1518–1526.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li EY, Huang WY, Chang YC, Tsai MH, Chuang
EY, Kuok QY, Bai ST, Chao LY, Sher YP and Lai LC: Aryl Hydrocarbon
receptor activates NDRG1 transcription under hypoxia in breast
cancer cells. Sci Rep. 6:208082016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma B, Cheng H, Mu C, Geng G, Zhao T, Luo
Q, Ma K, Chang R, Liu Q, Gao R, et al: The SIAH2-NRF1 axis
spatially regulates tumor microenvironment remodeling for tumor
progression. Nat Commun. 10:10342019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ge J, Mao L, Xu W, Fang W, Wang N, Ye D,
Dong Z, Guan H and Guan C: miR-103a-3p suppresses cell
proliferation and invasion by targeting tumor protein D52 in
prostate cancer. J Invest Surg. 1–9. Mar 13–2020.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu W, Wan X, Tao L and Wan J: Long
non-coding RNA HULC promotes cervical cancer cell proliferation,
migration and invasion via miR-218/TPD52 Axis. Onco Targets Ther.
13:1109–1118. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Li Y, Fan L, Zhao Q, Tan B, Liu R
and Li F: Silencing of TPD52 inhibits proliferation, migration,
invasion but induces apoptosis of pancreatic cancer cells by
deactivating Akt pathway. Neoplasma. 67:277–285. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Z, Wang J, Gao R, Yang X, Zhang Y,
Li J, Zhang J, Zhao X, Xi C and Lu X: Downregulation of
microRNA-449 promotes migration and invasion of breast cancer cells
by targeting tumor protein D52 (TPD52). Oncol Res. 25:753–761.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu R, Zou ST, Wan JM, Li W, Li XL and Zhu
W: BTG1 inhibits breast cancer cell growth through induction of
cell cycle arrest and apoptosis. Oncol Rep. 30:2137–2144. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malec V, Coulson JM, Urbé S and Clague MJ:
Combined analyses of the VHL and hypoxia signaling axes in an
isogenic pairing of renal clear cell carcinoma cells. J Proteome
Res. 14:5263–5272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alves MR, Carneiro FC, Lavorato-Rocha AM,
da Costa WH, da Cunha IW, de Cássio Zequi S, Guimaraes GC, Soares
FA, Carraro DM and Rocha RM: Mutational status of VHL gene and its
clinical importance in renal clear cell carcinoma. Virchows Arch.
465:321–330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kong W, He L, Richards EJ, Challa S, Xu
CX, Permuth-Wey J, Lancaster JM, Coppola D, Sellers TA, Djeu JY and
Cheng JQ: Upregulation of miRNA-155 promotes tumour angiogenesis by
targeting VHL and is associated with poor prognosis and
triple-negative breast cancer. Oncogene. 33:679–89. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu T, Ruan H, Gao S, Liu J, Liu Y, Song Z,
Cao Q, Wang K, Bao L, Liu D, et al: ISG20 serves as a potential
biomarker and drives tumor progression in clear cell renal cell
carcinoma. Aging (Albany NY). 12:1808–1827. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hamdan FH and Zihlif MA: Gene expression
alterations in chronic hypoxic MCF7 breast cancer cell line.
Genomics. 104:477–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Comerford KM, Wallace TJ, Karhausen J,
Louis NA, Montalto MC and Colgan SP: Hypoxia-inducible
factor-1-dependent regulation of the multidrug resistance (MDR1)
gene. Cancer Res. 62:3387–3394. 2002.PubMed/NCBI
|
|
41
|
Chen J, Ding Z, Peng Y, Pan F, Li J, Zou
L, Zhang Y and Liang H: HIF-1α inhibition reverses multidrug
resistance in colon cancer cells via downregulation of
MDR1/P-glycoprotein. PLoS One. 9:e988822014. View Article : Google Scholar : PubMed/NCBI
|
